Reneuron Share Discussion Threads

[ftangftang] 04/8/2015 09:42

Bioprocessing SummitToday 09:069:00 Stem Cell Therapy – The Road to Commercialization
Jasmin Kee, Ph.D., Head, Engineering, ReNeuron
Our lead product, CTX, is a therapy for the treatment of patients left disabled by a stroke and for critical limb ischaemia. Both treatments are currently in Phase I and II clinical trials. This presentation will discuss the challenges faced through clinical trials and the strategy to commercialization. Topics will include the use of contract manufacturers versus in-house manufacturing, process scale-up and the use of automation to meet clinical trial needs and future commercial supply.



cheers
ft ft

[yachtmaster2] 02/8/2015 12:42

Good morning RF. You may indeed be right. I do however only hold just over1M shares which represents less than a fraction of 1% of my otherwise relatively boring and income producing portfolio. So you really don't need to concern yourself with with me being "shafted "or "getting rich quick" I already am.
I have made a lot of money investing in Aim shares and believe this will be the next one. I do respect your contrarian view but would disagree with you. Stop worrying about us and go and play golf or something!

[rocket fuel] 01/8/2015 18:55

you had best hand around the lube then yachty because yourself and the rest of the beloved rene shareholders society are all gonna be taking an almighty one up the sphincter by the BoD and city friends by the time they've done with the mug punter wonder cure get rich quick speculators here!

[yachtmaster2] 01/8/2015 17:09

Excellent I enjoy a good correction. Reminds me of boarding school.

[rocket fuel] 01/8/2015 15:59

drip drip splosh! will be trading in the 3p range before the year is out. sit back and enjoy the correction boys and girls!

[bigspuds] 30/7/2015 16:45

Strong support at this level

[bigspuds] 21/7/2015 12:42

Yes, but they eventually will all be flushed out, it's the natural order of things

[investordave] 21/7/2015 11:31

A 6p bid price always seems to attract a raft of sellers. Today seems to be no different to usual in this respect.

[stewart_25] 21/7/2015 08:54

Looking good - RF must have bought back in!!! ;-) :-)

[beltd] 21/7/2015 06:57

Looks set to have another leg up here

[beltd] 20/7/2015 14:13

Well said Norbus. Let's not forget it's not just WOODFORD in here, although Obv he's a huge holder. With the potential of some extremely good news flow this year I think this looks strong

[norbus] 20/7/2015 08:32

rf

surely rene has moved boldly on; woodford would not risk his reputation on chicanery; yes it was present once, but Chris Evans is well diluted out. I think rene has never been closer to success; I do not hold

[14dragon] 19/7/2015 16:33

Clinical trials for Retinal Blindness.
Stem cell Exosomal Nanomedicine research re total destruction of cancer cells.
Larger phase trials 2 clinical trials for stroke.

These will all now be taken to their final conclusions using this new injection of capital.

Sorry Rocket but exciting times ahead for us invested in ReNeuron...it could be MASSIVE and you know it!

[philip49] 18/7/2015 22:48

Sore loser and last word freak, get another life luv. You just hate it when you're wrong, well get over it dear

[rocket fuel] 18/7/2015 20:33

you dont get it do you? nothing has changed here bar a windfall for the gravy train. forget the science here. this is the aim blag. there is nothing going through fda approval, on to manufacturing, into the pharma ecosystem and ultimately ringing into the cash tills and then some before they announce a profit for at least 7 years min. there will be plenty of 'in house' broker notes with amazing forecasts and projections over the next 24-36 months as this r&d company soak up what will be their last promise of cash on the never never Aim dairy. after they have fleeced you guys of £150m since ipo they will dump you via an early morning 'suspended due to financial clarification' rns on how they could not raise enough cash needed to go forward and continue the final most expensive cash burn period for trials every year it takes to bring a rene product to market. and hey ho they de-list for a private venture cap (city friends of course) to buy them out on the cheap, after all that lovely £150m r&d and ip was funded by the mug punter speculators on the Aim. haha, its obvious who will be ready to grab them on the cheap when the cash runs dry. and all the same people will own the company with all the familiar BoD faces but with a private company name above the door. haha, do you get it now?

[yachtmaster2] 18/7/2015 17:15

I believe the upside potential is indeed huge. It is certainly not a crowded trade yet but may hopefully become one in the near future with a bit of positive news.

[yachtmaster2] 18/7/2015 16:35

I would surmise that Rocket has bought at a much higher price and has perhaps lost a lot of money. I hate to see that happen to any investor. Indeed I have been there myself on occasions. It can leave one feeling rather embittered. You have to empathise with him.

[investordave] 18/7/2015 10:22

Thanks for the advice maden. I've now filtered. The negativity has got boring and I don't think rf realises that if just one of RENE's products is successful the company's share price will soar to many times its current valuation. This is a risk well worth taking in my view. Have a good weekend.

[madengland] 18/7/2015 10:17

Dave I would filter...... Am all for having a bear argument, but the poster you are responding to knows nothing.

[investordave] 18/7/2015 10:11

Short I meant.

[investordave] 18/7/2015 10:11

I assume you're sorry rf?